A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma
NCT05370807
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Melanoma Stage III
Melanoma Stage IV
Interventions
DRUG:
Regorafenib 40 MG Oral Tablet
DRUG:
Triplet therapy
Sponsor
Universitair Ziekenhuis Brussel